» Articles » PMID: 31508317

Muscle Injury Promotes Heterotopic Ossification by Stimulating Local Bone Morphogenetic Protein-7 Production

Overview
Publisher Elsevier
Specialty Orthopedics
Date 2019 Sep 12
PMID 31508317
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Heterotopic ossification (HO) is a pathological condition of abnormal bone formation in soft tissue, which causes pain and restricted range of motion in patients. There are two broad categories of HO, hereditary and acquired. Although different types of HO do not use identical mechanistic pathways of pathogenesis, muscle injury appears to be a unifying feature for all types of HO. However, little is known about the mechanisms by which muscle injury facilitates HO formation.

Objective And Method: This study aimed to explore the cellular and molecular mechanisms linking muscle injury to HO by using cardiotoxin to induce muscle injury in a bone morphogenetic protein-2 (BMP-2)-induced HO mouse model.

Results: We found that muscle injury augmented HO formation and that this effect was correlated with BMP signalling activation and upregulation of BMP-7 expression at the early phase of HO progression. We further demonstrated that inhibition of BMP-7 activity suppressed the osteogenesis-promoting effect of conditioned medium derived from injured muscle tissue and reduced the volume of HO formation. We also showed that antiinflammatory drug treatment reduced the volume of HO with concomitant reduction in BMP-7 production.

Conclusion: In summary, our study has identified BMP-7 as a key osteoinductive factor in injured muscle that facilitates HO formation.

The Translational Potential Of This Article: Our results provide a candidate mechanistic rationale for the use of antiinflammatory drugs in the prevention of HO.

Citing Articles

Bu Yang Huan Wu Prevents Osteogenic Effect of Muscle-Derived Stromal Cells via Regulating JAK/STAT Pathway.

Cao G, Zhang S, Liao Y, Yue C, Yang L, Guo J J Cell Mol Med. 2025; 29(3):e70413.

PMID: 39936922 PMC: 11816160. DOI: 10.1111/jcmm.70413.


A glucocorticoid spike derails muscle repair to heterotopic ossification after spinal cord injury.

Alexander K, Tseng H, Lao H, Girard D, Barbier V, Ungerer J Cell Rep Med. 2024; 5(12):101849.

PMID: 39657663 PMC: 11722129. DOI: 10.1016/j.xcrm.2024.101849.


Denervation‑induced NRG3 aggravates muscle heterotopic ossification via the ErbB4/PI3K/Akt signaling pathway.

Ma L, Kang X, Tan J, Wang Y, Liu X, Tang H Mol Med Rep. 2024; 31(1).

PMID: 39450542 PMC: 11529186. DOI: 10.3892/mmr.2024.13374.


Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification.

Juan C, Bancroft A, Choi J, Nunez J, Pagani C, Lin Y Biomolecules. 2024; 14(3).

PMID: 38540768 PMC: 10968060. DOI: 10.3390/biom14030349.


MEK-inhibitors decrease Nfix in muscular dystrophy but induce unexpected calcifications, partially rescued with Cyanidin diet.

Angelini G, Capra E, Rossi F, Mura G, Saclier M, Taglietti V iScience. 2024; 27(1):108696.

PMID: 38205246 PMC: 10777118. DOI: 10.1016/j.isci.2023.108696.


References
1.
Shehab D, Elgazzar A, Collier B . Heterotopic ossification. J Nucl Med. 2002; 43(3):346-53. View

2.
van Kuijk A, Geurts A, van Kuppevelt H . Neurogenic heterotopic ossification in spinal cord injury. Spinal Cord. 2002; 40(7):313-26. DOI: 10.1038/sj.sc.3101309. View

3.
McCarthy E, Sundaram M . Heterotopic ossification: a review. Skeletal Radiol. 2005; 34(10):609-19. DOI: 10.1007/s00256-005-0958-z. View

4.
Shore E, Xu M, Feldman G, Fenstermacher D, Cho T, Choi I . A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006; 38(5):525-7. DOI: 10.1038/ng1783. View

5.
Balboni T, Gobezie R, Mamon H . Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis. Int J Radiat Oncol Biol Phys. 2006; 65(5):1289-99. DOI: 10.1016/j.ijrobp.2006.03.053. View